Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-09

Clinical Trial Update: A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Artekin with standard malaria treatment regimens in Afghanistan has completed. The trial enrolled patients with uncomplicated falcipar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artekin (dihydroartemisinin/piperaquine)

Snippet

Sponsor: University of Oxford | Conditions: Uncomplicated Falciparum Malaria, Vivax Malaria | Phase 3 | Status: COMPLETED